Staff

BBOT Presents Preclinical Data Demonstrating Potential of BBO-11818 as a Potent panKRAS Inhibitor at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

SciSparc Announces Closing of the Sale to N2OFF of Majority-Owned Subsidiary MitoCareX, Advancing Drug Discovery for Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer

TEL AVIV, Israel, Oct. 23, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage...

Elevate Holistics Empowers U.S. Veterans Through Medical Cannabis Access — CEO Aspen Noonan Highlights New Federal & State-Level Progress

TULSA, Okla., Oct. 23, 2025 /PRNewswire/ -- Elevate Holistics, a telehealth platform dedicated to medically-supervised cannabis access, today announces its...

error: Content is protected !!